Amrutanjan Health Care Q4 Results
- BSE: 590006
- NSE: AMRUTANJAN
- ISIN: INE098F01031
- Sector: Biotechnology & Drugs
BSE
631.65
2.60 (0.41%)
2.60 (0.41%)Volume307.00
Updated: Fri 6 Feb, 2026 | 14:49:45
NSE
6344.35 (0.69%)
4.35 (0.69%)Volume6.17 K
Updated: Fri 6 Feb, 2026 | 15:25:45
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q4 Results Highlights
Quarter ended Mar 25
Note: Comparison is on QoQ basis
Quarterly - Amrutanjan Health Care Q4 Results
*All figures in crores except per share values
| Fiscal Period | Mar 25 | Dec 25 | QoQ Comp | Mar 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 119.33 | 118.75 | 18.07% | 112.36 | 6.21% |
| Depreciation/ Amortization | 1.62 | 1.62 | -2.51% | 1.53 | 5.75% |
| Operating Income | 16.08 | 22.29 | -25.85% | 14.70 | 9.36% |
| Net Income | 15.18 | 19.45 | -21.14% | 13.66 | 11.12% |
| Other Operating Expenses Total | 16.82 | 14.59 | 36.34% | 19.43 | -13.41% |
| Net Income Before Taxes | 20.86 | 26.36 | -19.75% | 19.60 | 6.38% |
| Total Revenue | 135.41 | 141.04 | 10.32% | 127.06 | 6.57% |
| Selling/ General/ Admin Expenses Total | 31.89 | 37.49 | 2.02% | 27.67 | 15.29% |
| Diluted Normalized EPS | 5.25 | 7.05 | -21.11% | 4.71 | 11.62% |